Rose, Steven P.R.
|DOI (Digital Object Identifier) Link:||http://doi.org/10.1038/nrn984|
|Google Scholar:||Look up in Google Scholar|
Beyond pharmacological approaches to the treatment of memory loss that results from Alzheimer's disease or stroke, there lies a broad diagnostic penumbra of 'age-associated memory impairment'. New research that offers to attain the ancient goal of improving our cognitive ability raises an important issue — the use, by healthy people, of such pharmacological tools as cognitive enhancers. Here, I review the history and effectiveness of such supposed 'nootropics', and the ethical, social and legal issues raised by their potential use in disease and in the enhancement of 'normal' cognition.
|Item Type:||Journal Article|
|Academic Unit/Department:||Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM)
|Depositing User:||Astrid Peterkin|
|Date Deposited:||02 Mar 2007|
|Last Modified:||02 Aug 2016 13:04|
|Share this page:|